IRIS
Del Re, Marzia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 561
SA - Sud America 389
NA - Nord America 196
EU - Europa 123
AF - Africa 27
OC - Oceania 2
Totale 1.298
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 351
SG - Singapore 338
US - Stati Uniti d'America 158
HK - Hong Kong 73
IT - Italia 64
VN - Vietnam 38
MX - Messico 26
BD - Bangladesh 22
CN - Cina 19
IQ - Iraq 17
GB - Regno Unito 15
AR - Argentina 11
IN - India 11
CO - Colombia 8
EC - Ecuador 8
NL - Olanda 8
TR - Turchia 8
ZA - Sudafrica 8
UA - Ucraina 7
DE - Germania 6
ID - Indonesia 6
CA - Canada 5
ES - Italia 5
SA - Arabia Saudita 5
VE - Venezuela 5
FR - Francia 4
RU - Federazione Russa 4
TN - Tunisia 4
UZ - Uzbekistan 4
KE - Kenya 3
NO - Norvegia 3
NP - Nepal 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
EG - Egitto 2
IE - Irlanda 2
JO - Giordania 2
LB - Libano 2
PK - Pakistan 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
CG - Congo 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RW - Ruanda 1
SE - Svezia 1
SO - Somalia 1
SV - El Salvador 1
UG - Uganda 1
Totale 1.298
Salva come PNG Salva come JPEG
Città #
Singapore 232
Hong Kong 66
Rome 36
Mexico City 20
São Paulo 19
Ho Chi Minh City 14
Rio de Janeiro 14
Santa Clara 13
Milan 12
Beijing 10
Ribeirão Preto 8
Brasília 7
Hanoi 7
Dhaka 6
New York 6
Belo Horizonte 5
Da Nang 4
Guarulhos 4
São José dos Campos 4
Tashkent 4
Vitória da Conquista 4
Ashburn 3
Atlanta 3
Bogotá 3
Campinas 3
Canoas 3
Cape Town 3
Ceres 3
Curitiba 3
Erbil 3
Fortaleza 3
Goiânia 3
Houston 3
Istanbul 3
Juazeiro do Norte 3
Montevideo 3
Nairobi 3
Natal 3
Porto Alegre 3
Quận Mười 3
Rondonópolis 3
San Antonio 3
Santo André 3
Tunis 3
Ambato 2
Amman 2
Anápolis 2
Araraquara 2
Baghdad 2
Baku 2
Baltimore 2
Biên Hòa 2
Boston 2
Campo Largo 2
Campo Novo do Parecis 2
Caracas 2
Caraguatatuba 2
Cleveland 2
Dammam 2
Dublin 2
Duque de Caxias 2
El Paso 2
Extrema 2
Governador Valadares 2
Greenville 2
Guayaquil 2
Iapu 2
Itajaí 2
Jacksonville 2
Jaipur 2
Kathmandu 2
La Paz 2
Las Vegas 2
Macau 2
Maceió 2
Magé 2
Mairiporã 2
Manaus 2
Melbourne 2
Mosul 2
Najaf 2
Niterói 2
Ourinhos 2
Passo Fundo 2
Paulo Afonso 2
Pelotas 2
Petrópolis 2
Philadelphia 2
Pisa 2
Poços de Caldas 2
Presidente Prudente 2
Pretoria 2
Pune 2
Raul Soares 2
Rio das Pedras 2
Riyadh 2
Salvador 2
Santa Cruz do Capibaribe 2
Sobral 2
Spring Valley 2
Totale 676
Salva come PNG Salva come JPEG
Nome #
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 19
EGFR signaling pathway as therapeutic target in human cancers 19
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients 15
Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer 15
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 14
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated Acute Myeloid Leukemia (AML) to guide treatment strategy 14
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 14
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors 13
Updates on liquid biopsy: Current trends and future perspectives for clinical application in solid tumors 13
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 13
Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: A systematic review protocol 12
The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma 12
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 12
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics 12
ANKRd44 gene silencing: A putative role in trastuzumab resistance in HER2-like breast cancer 12
Recommendations for using molecular assays on liquid biopsy: the first document provided by intersociety Group AIOM, SIF, SIAPEC-IAP, SIBioC | Raccomandazioni per l’esecuzione di indagini molecolari su biopsia liquida in oncologia 12
Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs 11
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 11
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 11
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes 11
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial 11
Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low-grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis? 10
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 10
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view 10
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 10
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years 10
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 10
Facing an un-met need in lung cancer screening: The never smokers 10
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 10
Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data 10
The tumor-agnostic treatment for patients with solid tumors: a position paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIF Italian Scientific Societies 10
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 10
Predicting Fluoropyrimidine-Related Toxicity: Turning Wish to Will, The Pamm-Eortc Position 10
Genome Wide Association Studies (GWAS) 10
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival 10
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 10
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial 10
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 10
Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting 10
Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice 10
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients 10
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 10
Cross-Linked Hyaluronic Acid as Tear Film Substitute 10
Monitoring of secondary drug resistance mutations in circulating tumor DNA of patients with advanced ALK positive NSCLC 10
Radiomics and liquid biopsy in oncology: the holons of systems medicine 10
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 10
Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation 9
Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA 9
Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy 9
Results of a comprehensive pharmacogenetic analysis of dihydropyrimidine dehydrogenase in patients treated with fluoropyrimidines and patterns of polymorphisms partially related to treatment tolerability 9
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA 9
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives 9
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 9
DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis 9
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment 9
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer 9
Empower the potential of trastuzumab deruxtecan with novel combinations 9
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer 9
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 9
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST) 9
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients 9
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 9
Response to Wirostko et al. Re: "Cross-Linked Hyaluronic Acid as Tear Film Substitute" by Posarelli et al. (J Ocul Pharmacol Ther 2019;35(7):381-387) 9
Matching BRCA and prostate cancer in a public health system: Report of the Italian Society for Uro-Oncology (SIUrO) consensus project 9
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors 9
Prediction of fluoropyrimidine toxicities by screening DPYD genetic variants 9
Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA: Individual patient data pooled analysis of CRICKET and CAVE trials 9
Should CYP2D6 be genotyped when treating with tamoxifen? 9
Pharmacogenetic foundations of therapeutic efficacy and adverse events of statins 8
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 8
Obesity and inflammatory response in moderate-to-severe acute respiratory distress syndrome: a single center pilot study 8
Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment 8
Liquid biopsies from pleural effusions and plasma from patients with malignant pleural mesothelioma: A feasibility study 8
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase 8
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 8
KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA 8
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer 8
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 8
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 8
Pharmacokinetic and pharmacogenetic predictive markers of irinotecan activity and toxicity 8
Crizotinib resensitization by compound mutation 8
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 8
Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer 8
Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines 8
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 8
Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine? 8
Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight 8
ErbB in NSCLC as a molecular target: Current evidences and future directions 8
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 8
Understanding EGFR heterogeneity in lung cancer 8
Author's reply. The detection of AR-V7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients 8
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients 8
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours 8
Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers 8
Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer Through Liquid Biopsy: Management of C797S Acquired Mutation 7
Pharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer 7
Nicotine Metabolite Ratio in Smokers: A Real World Experience 7
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients 7
Recent advances in epigenomics in NSCLC: Real-time detection and therapeutic implications 7
Detection of BRAF and KRAS mutations in DNA released by tumors in peripheral blood by an advanced digital droplet PCR 7
Totale 974
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.169 0 0 0 44 19 50 69 149 168 33 309 328
2025/2026336 176 38 122 0 0 0 0 0 0 0 0 0
Totale 1.505